Cleared Traditional

K201742 - eKuore One Wireless Electronic Interfac...

K201742 is an FDA 510(k) clearance for eKuore One Wireless Electronic Interfac..., manufactured by Chip Ideas Electronics S.L.. The device is a Class 2 Cardiovascular device with product code DQD cleared through the Traditional 510(k) pathway after a 152-day FDA review.

K201742 · Chip Ideas Electronics S.L. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2020
Decision
152d
Days
Class 2
Risk

K201742 is an FDA 510(k) clearance for the eKuore One Wireless Electronic Interface for stethoscope. Classified as Stethoscope, Electronic (product code DQD), Class II - Special Controls.

Submitted by Chip Ideas Electronics S.L. (Burjasot, ES). The FDA issued a Cleared decision on November 24, 2020 after a review of 152 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1875 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Chip Ideas Electronics S.L. devices

FDA 510(k) Submission Details - K201742

510(k) Number K201742 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 25, 2020
Decision Date November 24, 2020
Days to Decision 152 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
27d slower than avg
Panel avg: 125d · This submission: 152d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQD Device Classification - Class 2, Special Controls

Product Code DQD Stethoscope, Electronic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1875
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQD Stethoscope, Electronic

All 58
Devices cleared under the same product code (DQD) and FDA review panel - the closest regulatory comparables to K201742.
PrevisEA Device
K211068 · Entac Medical, Inc. · Aug 2021
doctorgram Stethoscope DES-I
K210736 · Gv Concepts · Jul 2021
MyHomeDoc
K202483 · Myhomedoc , Ltd. · Mar 2021
eKuore Pro Series
K203007 · Chip Ideas Electronics S.L. · Oct 2020
Stethee Pro 1, Stethee Pro Software System
K193631 · M3Dicine Pty , Ltd. · Oct 2020
Feelix Stethoscope
K200862 · Sonavi Labs, Inc. · Sep 2020